Lysosomal dysfunction in diabetic cardiomyopathy

被引:3
|
作者
Kobayashi, Satoru [1 ]
Hahn, Younghee [1 ]
Silverstein, Brett [1 ]
Singh, Mandeep [1 ]
Fleitz, Adeline [1 ]
Van, Jennifer [1 ]
Chen, Hongling [1 ]
Liang, Qiangrong [1 ]
机构
[1] New York Inst Technol, Coll Osteopath Med, Dept Biomed Sci, New York, NY 10023 USA
来源
FRONTIERS IN AGING | 2023年 / 4卷
基金
美国国家卫生研究院;
关键词
diabetes; cardiovascular; lysosome; autophagy; lysosomal membrane damage; cardiomyopathy; CATHEPSIN-D; VITAMIN-E; CARDIOVASCULAR-DISEASE; PRIMARY PREVENTION; OXIDATIVE STRESS; SEX-DIFFERENCES; HEART-DISEASE; AUTOPHAGY; STREPTOZOTOCIN; ENZYMES;
D O I
10.3389/fragi.2023.1113200
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Diabetes is a major risk factor for a variety of cardiovascular complications, while diabetic cardiomyopathy, a disease specific to the myocardium independent of vascular lesions, is an important causative factor for increased risk of heart failure and mortality in diabetic populations. Lysosomes have long been recognized as intracellular trash bags and recycling facilities. However, recent studies have revealed that lysosomes are sophisticated signaling hubs that play remarkably diverse roles in adapting cell metabolism to an ever-changing environment. Despite advances in our understanding of the physiological roles of lysosomes, the events leading to lysosomal dysfunction and how they relate to the overall pathophysiology of the diabetic heart remain unclear and are under intense investigation. In this review, we summarize recent advances regarding lysosomal injury and its roles in diabetic cardiomyopathy.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] LYSOSOMAL-ENZYMES IN EXPERIMENTAL DIABETIC CARDIOMYOPATHY
    GIACOMELLI, F
    SKOZA, L
    WIENER, J
    CLINICAL BIOCHEMISTRY, 1980, 13 (05) : 227 - 231
  • [2] Endothelial Dysfunction and Diabetic Cardiomyopathy
    Wang, Moran
    Li, Yongsheng
    Li, Sheng
    Lv, Jiagao
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [3] Metabolic dysfunction in diabetic cardiomyopathy
    Michael Isfort
    Sarah C. W. Stevens
    Stephen Schaffer
    Chian Ju Jong
    Loren E. Wold
    Heart Failure Reviews, 2014, 19 : 35 - 48
  • [4] Mitochondrial dysfunction in diabetic cardiomyopathy
    Duncan, Jennifer G.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2011, 1813 (07): : 1351 - 1359
  • [5] Metabolic dysfunction in diabetic cardiomyopathy
    Isfort, Michael
    Stevens, Sarah C. W.
    Schaffer, Stephen
    Jong, Chian Ju
    Wold, Loren E.
    HEART FAILURE REVIEWS, 2014, 19 (01) : 35 - 48
  • [6] LYSOSOMAL AND NONLYSOSOMAL PROTEOLYTIC ACTIVITIES IN EXPERIMENTAL DIABETIC CARDIOMYOPATHY
    KUO, TH
    GIACOMELLI, F
    WIENER, J
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 1984, 40 (03) : 280 - 287
  • [7] Mitochondrial Dysfunction is Involved in Diabetic Cardiomyopathy
    Xu, Frank
    Ho, Li-Lun
    Lu, Tzongshi
    CIRCULATION, 2021, 144
  • [8] Molecular Dysfunction and Phenotypic Derangement in Diabetic Cardiomyopathy
    Evangelista, Isabella
    Nuti, Ranuccio
    Picchioni, Tommaso
    Dotta, Francesco
    Palazzuoli, Alberto
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (13)
  • [9] Coronary microvascular dysfunction in overt diabetic cardiomyopathy
    Bratis, K.
    Child, N.
    Terrovitis, J.
    Nanas, J.
    Felekos, I.
    Aggeli, C.
    Stefanadis, C.
    Mastorakos, G.
    Chiribiri, A.
    Nagel, E.
    Mavrogeni, S.
    IJC METABOLIC & ENDOCRINE, 2014, 5 : 19 - 23
  • [10] DIABETIC CARDIOMYOPATHY - MEMBRANE DYSFUNCTION AND THERAPEUTIC STRATEGIES
    GANGULY, PK
    PIERCE, GN
    DHALLA, NS
    JOURNAL OF APPLIED CARDIOLOGY, 1987, 2 (04) : 323 - 338